Increased T cell reactivity to amyloid β protein in older humans and patients with Alzheimer disease
Alon Monsonego(Ben-Gurion University of the Negev), Howard L. Weiner(Baylor College of Medicine), Gal Bitan(University of California, Los Angeles), Andrew E. Budson(VA Boston Healthcare System), Victor Zota(Harvard University), Arnon Karni(Harvard University), Amit Bar‐Or(University of Pennsylvania), Reisa A. Sperling(Harvard University), Dennis J. Selkoe(Brigham and Women's Hospital), Jeffery I. Krieger(Harvard University)
Cited by 295
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k